Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
2015
Wernli, 2017, Antimicrobial resistance: the complex challenge of measurement to inform policy and the public, PLoS Med, 14, e1002378, 10.1371/journal.pmed.1002378
de Kraker, 2016, Will 10 million people die a year due to antimicrobial resistance by 2050?, PLoS Med, 13, e1002184, 10.1371/journal.pmed.1002184
Stewardson, 2016, The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study, Euro Surveill, 21, 30319, 10.2807/1560-7917.ES.2016.21.33.30319
2017, ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals, EFSA J, 15, e05017
Kretzschmar, 2012, New methodology for estimating the burden of infectious diseases in Europe, PLoS Med, 9, e1001205, 10.1371/journal.pmed.1001205
Murray, 2012, GBD 2010: design, definitions, and metrics, Lancet, 380, 2063, 10.1016/S0140-6736(12)61899-6
Haagsma, 2015, Assessing disability weights based on the responses of 30 660 people from four European countries, Popul Health Metr, 13, 10, 10.1186/s12963-015-0042-4
Cassini, 2016, Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study, PLoS Med, 13, e1002150, 10.1371/journal.pmed.1002150
Colzani, 2017, A software tool for estimation of burden of infectious diseases in Europe using incidence-based disability adjusted life years, PLoS One, 12, e0170662, 10.1371/journal.pone.0170662
Mangen, 2013, The pathogen- and incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of infectious diseases, PLoS One, 8, e79740, 10.1371/journal.pone.0079740
Cassini, 2018, Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013, Euro Surveill, 23, 17, 10.2807/1560-7917.ES.2018.23.16.17-00454
2013
Colomb-Cotinat, 2016, Estimating the morbidity and mortality associated with infections due to multidrug-resistant bacteria (MDRB), France, 2012, Antimicrob Resist Infect Control, 5, 56, 10.1186/s13756-016-0154-z
Crnich, 2013, Impact and management of MRSA in the long-term care setting, Curr Transl Geriatr Exp Gerontol Rep, 2, 125, 10.1007/s13670-013-0047-4
Sarvikivi E, Ollgren J, Lyytikäinen O. Trends and outcome of healthcare-associated and community-onset bloodstream infections due to Staphylococcus aureus in Finland 2004–2015. European Scientific Conference on Applied Infectious Disease Epidemiology; Stockholm; Nov 6–8, 2017.
Di Ruscio, 2017, MRSA infections in Norway: a study of the temporal evolution, 2006–2015, PLoS One, 12, e0179771, 10.1371/journal.pone.0179771
Albiger, 2015, Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015, Euro Surveill, 20, 30062, 10.2807/1560-7917.ES.2015.20.45.30062
Grundmann, 2017, Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study, Lancet Infect Dis, 17, 153, 10.1016/S1473-3099(16)30257-2
Umscheid, 2011, Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs, Infect Control Hosp Epidemiol, 32, 101, 10.1086/657912
Magiorakos, 2017, Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control, Antimicrob Resist Infect Control, 6, 113, 10.1186/s13756-017-0259-z
Davey, 2017, Interventions to improve antibiotic prescribing practices for hospital inpatients, Cochrane Database Syst Rev, 2